Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma
Laurence Albiges, Tom Powles, Michael Staehler, Karim Bensalah, Rachel H. Giles, Milan Hora, Markus A. Kuczyk, Thomas B. Lam, Börje Ljungberg, Lorenzo Marconi, Axel S. Merseburger, Alessandro Volpe, Yasmin Abu-Ghanem, Saeed Dabestani, Sergio Fernández-Pello, Fabian Hofmann, Teele Kuusk, Rana Tahbaz, Axel Bex*
*Corresponding author for this work
- Université Paris-Saclay
- Queen Mary University of London
- Ludwig-Maximilians-Universität
- University of Rennes
- Utrecht University
- Charles University
- Hannover Medical School
- University of Aberdeen
- Umeå University
- Hospital Pediátrico de Coimbra
- Ospedale Maggiore
- Chaim Sheba Medical Center Israel
- Lund University
- Hospital de Cabuenes
- Sunderby Hospital
- Royal Free Hospital NHS Foundation Trust
- Elbe-Kliniken
187
Link opens in a new tab
Citations
(Scopus)